$0.524
-0.048 (-9.14%)收盘时
- 最高
- 0.595
- 开盘
- 0.548
- 成交量加权均价
- 0.55
- 成交量
- 10.10K
- 市值
- —
- 最低
- 0.520
- 成交额
- 5.52K
- 企业价值/息税折旧摊销前利润(TTM)
- -1.44
Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform.
AI 分析 of Health In Tech Inc (HIT)
买入Health In Tech, Inc. appears to be a good buy right now due to its current price of $0.58, which is significantly below its 52-week high of $3.11, indicating potential for recovery. The RSI is at 43.33, suggesting the stock is not overbought, and the recent 5-day change of +9.12% shows positive momentum. However, the main risk is the projected EPS of -0.06 for the next earnings report, indicating ongoing profitability challenges.
估值指标
事件时间线
资讯
9.510-29PRnewswireHealth In Tech to Release Q3 2026 Financial Results on November 12
5.010-20PRnewswireHealth In Tech Appoints New CEO to Drive Growth
1.010-16PRnewswireHealth In Tech to Host 2026 Annual Stockholders Meeting
1.010-02PRnewswireHealth In Tech to Participate in Craig-Hallum Conference
1.010-02NewsfilterHealth In Tech to Participate in Investor Conference
HIT 常见问题 —— 由 Alphio AI 解答
Health In Tech, Inc. is an AI-enabled insurance technology platform company. The Company offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. It offers a marketplace designed to create healthcare plan solutions while streamlining processes through vertical integration, process simplification, and automation. Its services are delivered through three subsidiaries: Stone Mountain Risk, LLC (SMR), International Captive Exchange, LLC (ICE), and HI Card LLC’s HI Card platform (HI Card). The SMR is a program manager specializing in customized self-funded programs for small businesses. ICE is a managing general underwriter. ICE assists with underwriting activities through its Web-based SaaS quoting platform, Enhance Do It Yourself Benefit System (eDIYBS). HI Card seeks to simplify healthcare management with a single standardized transaction and service platform. It operates in the Financials sector.
Health In Tech, Inc. appears to be a good buy right now due to its current price of $0.58, which is significantly below its 52-week high of $3.11, indicating potential for recovery. The RSI is at 43.33, suggesting the stock is not overbought, and the recent 5-day change of +9.12% shows positive momentum. However, the main risk is the projected EPS of -0.06 for the next earnings report, indicating ongoing profitability challenges.
社区
更多 ↗暂无帖子
注册或登录后参与讨论相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。